Skip to content

Author

G. Tesini

We have 3 of 30 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Prognostic stratification of patients with biliary tract cancer treated with chemoimmunotherapy: A retrospective multicenter real‐world study

The objective of this study is to explore and validate a novel prognostic index for patients with locally advanced or metastatic biliary tract cancer (BTC) treated with first‐line therapy with cisplatin, gemcitabine, and durvalumab.

M. Persano, A. Casadei-Gardini, L. Fornaro et al. · 0 citations
Review Open access Sep 2026

Systemic treatment paradigms for unresectable and advanced hepatocellular carcinoma in Europe

Summary The management of unresectable and advanced hepatocellular carcinoma (HCC) has been transformed by the introduction of immune checkpoint inhibitor-based combinations, which have improved response and survival and expanded first-line treatment options. The availability of multiple effective regimens has introduc...

D. Pinato, E. Alimenti, Pasquale Lombardi et al. · 1 citation
Open access Aug 2026

Chronic liver disease is associated with earlier-stage cholangiocarcinoma diagnosis and improved prognosis: Findings from the GLOBAL-BTC registry.

Pre-existing CLD is associated with earlier-stage CCA diagnosis and improved survival, supporting the implementation of structured surveillance strategies in high-risk CLD populations and highlighting the need to optimize strategies for selected moderate-to-high risk CLD populations.

L. Izquierdo-Sánchez, J. Narbaiza, Julen Martin-Robles et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.